FDA Warns Consumers about Counterfeit Alli : RushPRNews - Newswire & Global Press Release Distribution

 
Bookmark and Share

FDA Warns Consumers about Counterfeit Alli

January 19, 2010

Washington, DC (rushPRnews) 01/19/10 — The counterfeit products contain controlled substance sibutramine

The U.S. Food and Drug Administration is today warning consumers about a counterfeit and potentially harmful version of Alli 60 mg capsules (120 count refill kit).

Preliminary laboratory tests conducted by GlaxoSmithKline (GSK)—the maker of the FDA approved over-the-counter weight-loss product— revealed that the counterfeit version did not contain orlistat, the active ingredient in its product. Instead, the counterfeit product contained the controlled substance sibutramine. Sibutramine is a drug that should not be used in certain patient populations or without physician oversight. Sibutramine can also interact in a harmful way with other medications the consumer may be taking.

Consumers began reporting suspected counterfeit Alli to GSK in early December 2009. GSK has determined that the counterfeit product has been sold over the internet. However, there is no evidence at this time that the counterfeit Alli product has been sold through other channels, such as retail stores.

The counterfeit Alli product looks similar to the authentic product, with a few notable differences. The counterfeit Alli has:

Outer cardboard packaging missing a “Lot” code;

Expiration date that includes the month, day, and year (e.g., 06162010); authentic Alli expiration date includes only the month and year (e.g.,: 05/12);

Packaging in a plastic bottle that has a slightly taller and wider cap with coarser ribbing than the genuine product;

Plain foil inner safety seal under the plastic cap without any printed words; the authentic product seal is printed with “SEALED for YOUR PROTECTION”;

Contains larger capsules with a white powder, instead of small white pellets.

Consumers who believe they have received counterfeit Alli are asked to contact the FDA's Office of Criminal Investigations (OCI) by calling 800-551-3989 or by visiting the OCI Web site (http://www.fda.gov/OCI).

Health care professionals and consumers are encouraged to report adverse events that may be related to the use of these counterfeit products to the FDA's MedWatch Program by phone at 1-800-FDA-1088, by fax at 1-800-FDA-0178, or by mail at: MedWatch, HF-2, FDA, 5600 Fishers Lane, Rockville, MD 20852-9787.

 

Media Web Address: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm197857.htm
About the author:

FDA is an agency within the Department of Health and Human Services and consists of seven centers and offices

Click here to see all news from this author/company

Filed Under: FDA- Pharmaceutical news, Health and Fitness, Lifestyle, PRESS RELEASE

RUSH PR NEWS newswire and press release services at rushprnews.com / AH Marketing ahmarketinggroup.com

Content- Legal Responsibility - All material is copyrighted - You may repost but you MUST link back to the original post on your page and acknowledge Rush PR News as the news source. Rush PR News is not legally and/or morally responsible for content of press releases, opinions expressed or fact-checking.

Rush PR News cannot be held legally responsible for material published and distributed through its newswire service or published in its press-room and therefore cannot be sued for published material. Third-party must be contacted directly to dispute content.

Rush PR News is not the contact for material published.

RSSFeed PRESS & SOCIAL MEDIA RELEASES

Charges Announced in Massive Cyber Intrusion Case

Washington, DC 03/15/17 · Two of the Perpetrators Believed to be Russian...

Roc Nation Announces New Start Up Platform, ARRIVE

SAN FRANCISCO 03/08/17 · Roc Nation, a full-service entertainment company founded by...

How to Become a Real Estate Guru

SANTA CRUZ 03/07/17 · Many people often consider investing their finances into...

Worldwide Online Research Project Invites Volunteers to Explore their own Minds

PALO ALTO, CA 03/06/17 · A largely student-led online psychological  investigation called the...

Women, Violent Extremism and the Internet: Empowering Prevention; Dealing with Risk

Ottawa, ON. Canada 03/01/17 · Women, Violent extremism and the Internet: Empowering Prevention...

Twisted Tales Cosmetics | A Daring New Twist on Matte Lipsticks

Vancouver, BC 02/26/17 · Women will be inspired to celebrate their womanhood...

Jennifer Aniston, Matt Damon, Meryl Streep and Many More Announced as Oscars Presenters

Hollywood, California 02/26/17 · Jennifer Aniston, Jason Bateman, Warren Beatty, Sofia Boutella,...

Newborn Foundation Named 2017 Community Impact Award Finalist


Saint Paul, MN 02/23/17 · Winners will be announced at the gala on...

Five Top Tips To Reduce Your Energy Bills

Bradford, Yorkshire, UK 02/22/17 · Here’s Some Great Energy Saving Tips That Work Are...

Flipkart and Microsoft forge cloud partnership to expand e-commerce in India

Redmond, WA 02/20/17 · Microsoft Corp. and Flipkart, India’s leading marketplace, on...

Neurobiologix Launches Methylation Pro Topical Formula

Austin, TX 02/20/17 · Methylation Pro Topical Formula features the addition of...

Coffee With Dr. Stewart Health Radio Show Launches Season 3

Austin, TX 01/30/17 · Coffee with Dr. Stewart - Season Three  Deciding to...

New Data Released by AAMC on the Current State of the Medical Workforce

San Francisco, CA 01/15/17 · If you have heard it once you have...

December Rose releases new album "Inside Out"

Los Angeles, CA/Montreal, Canada 01/10/17 ·   Invitation Records is excited to announce the...